Kawasaki disease in children: diagnosis, treatment, and therapeutic guidelines in light of a clinical case
 
More details
Hide details
1
Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Kraków University, Kraków, Poland
 
2
Ludwik Rydygier Specialist Hospital, Kraków, Poland
 
3
Stefan Żeromski Specialist Hospital, Kraków, Poland
 
 
Corresponding author
Mateusz Heba   

Szpital Specjalistyczny im. Stefana Żeromskiego, os. Na Skarpie 66, 31-913 Kraków
 
 
Ann. Acad. Med. Siles. 2025;79:115-118
 
KEYWORDS
TOPICS
ABSTRACT
Kawasaki disease (KD) is an acute inflammation of small- and medium-sized arteries of unknown etiology. It most commonly affects children under the age of 5, with a peak incidence at 2 years of age. Because of its nonspecific symptoms, the diagnostic process is prolonged and challenging. The primary symptoms include a high fever persisting for more than 5 days, lymphadenopathy, and skin changes. Other symptoms may include mucosal redness and cracking, “strawberry tongue”, conjunctivitis, swelling of the hands and feet with sheet-like peeling of the skin, and desquamation in the perineal area. This article presents the case of a 2-year-old boy admitted to the pediatric department of a hospital due to a high fever lasting several days, elevated inflammatory markers, and diarrhea. During hospitalization, new symptoms were observed, allowing the diagnosis of incomplete Kawasaki syndrome. The patient was treated according to European standards with a favorable therapeutic outcome and was monitored in a cardiology clinic. The boy was discharged in good condition without complications. This case highlights KD as both a diagnostic and therapeutic challenge, especially in its incomplete and atypical forms.
REFERENCES (12)
1.
Ramphul K., Mejias S.G. Kawasaki disease: a comprehensive review. Arch. Med. Sci. Atheroscler. Dis. 2018; 3(1): e41–e45, doi: 10.5114/amsad.2018.74522.
 
2.
Rowley A.H. Is Kawasaki disease an infectious disorder? Int. J. Rheum. Dis. 2018; 21(1): 20–25, doi: 10.1111/1756-185X.13213.
 
3.
Rowley A.H. Kawasaki disease: novel insights into etiology and genetic susceptibility. Annu. Rev. Med. 2011; 62: 69–77, doi: 1146/annurev-med-042409-151944.
 
4.
McCrindle B.W., Rowley A.H., Newburger J.W., Burns J.C., Bolger A.F., Gewitz M. et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American Heart Association. Circulation 2017; 135(17): e927–e999, doi: 10.1161/CIR.0000000000000484.
 
5.
Kuo H.C. Diagnosis, progress, and treatment update of Kawasaki disease. Int. J. Mol. Sci. 2023; 24(18): 13948, doi: 10.3390/ijms241813948.
 
6.
Yu J.J. Diagnosis of incomplete Kawasaki disease. Korean J. Pediatr. 2012; 55(3): 83–87, doi: 10.3345/kjp.2012.55.3.83.
 
7.
Buda P., Friedman-Gruszczyńska J., Książyk J. Anti-inflammatory treatment of Kawasaki disease: comparison of current guidelines and perspectives. Front. Med. (Lausanne) 2021; 8: 738850, doi: 10.3389/fmed.2021.738850.
 
8.
Hosseininasab A., Pashang F., Rukerd M.R.Z., Mirkamali H., Nakhaie M., Sayyadi A. Kawasaki disease in children: a retrospective cross-sectional study. Reumatologia 2023; 61(3): 152–160, doi: 10.5114/reum/163170.
 
9.
Mărginean C.O., Meliţ L.E., Mărginean M.O. The peculiarities of Kawasaki disease at the extremes of age: two case reports. Medicine (Baltimore) 2019; 98(42): e17595, doi: 10.1097/MD.0000000000017595.
 
10.
Owens A.M., Plewa M.C. Kawasaki Disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.
 
11.
Lin M.T., Wu M.H. The global epidemiology of Kawasaki disease: review and future perspectives. Glob. Cardiol. Sci. Pract. 2017; 2017(3): e201720, doi: 10.21542/gcsp.2017.20.
 
12.
Mastrangelo G., Cimaz R., Calabri G.B., Simonini G., Lasagni D., Resti M. et al. Kawasaki disease in infants less than one year of age: an Italian cohort from a single center. BMC Pediatr. 2019; 19(1): 321, doi: 10.1186/s12887-019-1695-0.
 
eISSN:1734-025X
Journals System - logo
Scroll to top